Mereo BioPharma Group (MREO) News Today $3.56 -0.02 (-0.56%) (As of 10:31 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is Leerink Partnrs' Forecast for MREO FY2024 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Stock analysts at Leerink Partnrs issued their FY2024 EPS estimates for Mereo BioPharma Group in a research report issued on Monday, November 18th. Leerink Partnrs analyst J. Schwartz anticipates that the company will post earnings of $0.06November 21 at 6:32 AM | marketbeat.comWhat is Leerink Partnrs' Forecast for MREO Q1 Earnings?Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Mereo BioPharma Group in a report released on Monday, November 18th. Leerink Partnrs analyst J. Schwartz expects that the company will post earnings per shareNovember 20 at 6:39 AM | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Sets New 52-Week Low - Here's WhyNovember 17, 2024 | americanbankingnews.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 52-Week Low - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Hits New 52-Week Low - Here's What HappenedNovember 15, 2024 | marketbeat.comMereo Biopharma Group Plc: Positive Developments and Strong Growth Potential Justify Buy RatingNovember 14, 2024 | markets.businessinsider.comPositive Outlook for Mereo Biopharma Group Plc Amidst Promising Therapeutic Developments and Strong Financial PositionNovember 14, 2024 | markets.businessinsider.comMereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comMereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comMereo BioPharma Group (NASDAQ:MREO) Shares Down 4.4% - Time to Sell?Mereo BioPharma Group (NASDAQ:MREO) Stock Price Down 4.4% - Here's WhyNovember 4, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 6.4% - Here's WhyMereo BioPharma Group (NASDAQ:MREO) Shares Down 6.4% - Time to Sell?October 23, 2024 | marketbeat.comIs Mereo BioPharma Group (MREO) the Hottest Penny Stock to Invest in According to Hedge Funds?October 16, 2024 | msn.comMillennium Management LLC Buys 1,022,570 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)Millennium Management LLC grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 46.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,201,705 shares of the company's stock aOctober 8, 2024 | marketbeat.comMarshall Wace LLP Takes Position in Mereo BioPharma Group plc (NASDAQ:MREO)Marshall Wace LLP bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,144,051 shares of the company's stock, valued at approximately $October 3, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $7.00 price objective on shares of Mereo BioPharma Group in a research report on Tuesday.October 1, 2024 | marketbeat.comPerceptive Advisors LLC Invests $4.51 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Perceptive Advisors LLC bought a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,253,250 shares of the company's stock, valued at approximatSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)Frazier Life Sciences Management L.P. bought a new position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,401,371 shares of the company's stock, valued at approximSeptember 29, 2024 | marketbeat.comBlue Owl Capital Holdings LP Takes $3.23 Million Position in Mereo BioPharma Group plc (NASDAQ:MREO)Blue Owl Capital Holdings LP acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 897,809 shares of the company's stock, valued at approSeptember 28, 2024 | marketbeat.comDeerfield Management Company L.P. Series C Invests $24.16 Million in Mereo BioPharma Group plc (NASDAQ:MREO)Deerfield Management Company L.P. Series C acquired a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,710,September 26, 2024 | marketbeat.comIntegral Health Asset Management LLC Has $6.39 Million Stock Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)Integral Health Asset Management LLC increased its position in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 86.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,775,000 shares of the company'September 23, 2024 | marketbeat.comRubric Capital Management LP Grows Position in Mereo BioPharma Group plc (NASDAQ:MREO)Rubric Capital Management LP grew its stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) by 12.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,307,347 shares of the company's stock after purchasing an additiSeptember 21, 2024 | marketbeat.comMereo BioPharma Group plc (MREO): A Bull Case TheorySeptember 18, 2024 | msn.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Up to $3.95September 18, 2024 | marketbeat.comJohn A. Lewicki Sells 5,212 Shares of Mereo BioPharma Group plc (NASDAQ:MREO) StockSeptember 17, 2024 | insidertrades.comCantor Fitzgerald Reaffirms Overweight Rating for Mereo BioPharma Group (NASDAQ:MREO)Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $7.00 price target on shares of Mereo BioPharma Group in a report on Monday.September 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Sees Unusually-High Trading VolumeMereo BioPharma Group (NASDAQ:MREO) Sees Large Volume IncreaseSeptember 13, 2024 | marketbeat.comMereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comMereo BioPharma Group (NASDAQ:MREO) Trading Down 4.9%Mereo BioPharma Group (NASDAQ:MREO) Shares Down 4.9%September 12, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Shares Up 3.3%Mereo BioPharma Group (NASDAQ:MREO) Stock Price Up 3.3%September 10, 2024 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Director Deepika Pakianathan Sells 105,244 SharesAugust 24, 2024 | insidertrades.comInsider Selling: Mereo BioPharma Group plc (NASDAQ:MREO) Director Sells 105,244 Shares of StockMereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) Director Deepika Pakianathan sold 105,244 shares of the business's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $4.43, for a total transaction of $466,230.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.August 23, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Trading 5.8% Higher Mereo BioPharma Group (NASDAQ:MREO) Stock Price Up 5.8%August 23, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $4.55Mereo BioPharma Group (NASDAQ:MREO) Sets New 1-Year High at $4.55August 22, 2024 | marketbeat.comStrong Buy Rating for Mereo Biopharma Amidst Promising Drug Program DevelopmentsAugust 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Mereo Biopharma on Strong Financials and Promising Pipeline ProgressAugust 16, 2024 | markets.businessinsider.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Up 4.9%Mereo BioPharma Group (NASDAQ:MREO) Trading Up 4.9%August 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.8%Mereo BioPharma Group (NASDAQ:MREO) Stock Price Down 2.8%August 15, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $3.82Mereo BioPharma Group (NASDAQ:MREO) Sets New 12-Month High at $3.82August 14, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Hits New 12-Month Low at $3.64Mereo BioPharma Group (NASDAQ:MREO) Hits New 12-Month Low at $3.64August 13, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Given Buy Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $7.00 price target on shares of Mereo BioPharma Group in a research note on Tuesday.August 13, 2024 | marketbeat.comMereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 13, 2024 | globenewswire.com991,971 Shares in Mereo BioPharma Group plc (NASDAQ:MREO) Purchased by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD bought a new stake in shares of Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 991,971 shareAugust 6, 2024 | marketbeat.comJanus Henderson Group PLC Purchases New Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)Janus Henderson Group PLC purchased a new stake in Mereo BioPharma Group plc (NASDAQ:MREO - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,120,573 shares of the company's stock, valued at approximately $16,949,000. JanuAugust 1, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Trading Up 5.3%Mereo BioPharma Group (NASDAQ:MREO) Shares Up 5.3%July 29, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Trading Down 3.1%Mereo BioPharma Group (NASDAQ:MREO) Shares Down 3.1%July 16, 2024 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Shares Gap Down to $3.60Mereo BioPharma Group (NASDAQ:MREO) Shares Gap Down to $3.60July 1, 2024 | marketbeat.comMereo BioPharma: Positioned For Potential BreakthroughsJune 30, 2024 | seekingalpha.comMereo BioPharma Group plc (NASDAQ:MREO) Insider Sells $27,365.04 in StockJune 29, 2024 | insidertrades.comJohn A. Lewicki Sells 7,416 Shares of Mereo BioPharma Group plc (NASDAQ:MREO) StockMereo BioPharma Group plc (NASDAQ:MREO - Get Free Report) insider John A. Lewicki sold 7,416 shares of Mereo BioPharma Group stock in a transaction on Tuesday, June 25th. The stock was sold at an average price of $3.69, for a total transaction of $27,365.04. Following the transaction, the insider now directly owns 65,587 shares of the company's stock, valued at $242,016.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.June 27, 2024 | marketbeat.comQ4 2024 EPS Estimates for Mereo BioPharma Group plc (NASDAQ:MREO) Decreased by AnalystMereo BioPharma Group plc (NASDAQ:MREO - Free Report) - Equities researchers at Leerink Partnrs cut their Q4 2024 earnings per share (EPS) estimates for Mereo BioPharma Group in a report issued on Wednesday, June 19th. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post eJune 24, 2024 | marketbeat.comSVB Leerink Raises Mereo BioPharma Group (NASDAQ:MREO) Price Target to $8.00SVB Leerink boosted their target price on shares of Mereo BioPharma Group from $6.00 to $8.00 and gave the company an "outperform" rating in a research note on Thursday.June 20, 2024 | marketbeat.com Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. MREO Media Mentions By Week MREO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.150.46▲Average Medical News Sentiment MREO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼82▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APGE News Today NAMS News Today CNTA News Today IRON News Today HRMY News Today EVO News Today TARS News Today GLPG News Today XNCR News Today RXRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
